Literature DB >> 1895928

Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5: role of the 110 kilodalton hemolysin in virulence and immunoprotection.

T J Inzana1, J Todd, J N Ma, H Veit.   

Abstract

To determine the role of hemolysin(s) in virulence and immunoprotection, non-hemolytic mutants of Actinobacillus pleuropneumoniae serotype 5, strain J45, were isolated following chemical mutagenesis. One mutant was selected for extensive characterization. Differences in capsule content, or in lipopolysaccharide or membrane protein electrophoretic profiles of the parent and mutant were not detected. A predominant, calcium-inducible protein of 110 kDa was present in culture supernatant of the parent, but absent from the mutant. Two-dimensional (2-D) gel electrophoresis confirmed that the 110 kDa protein was absent in culture supernatant of the mutant, but few, if any, minor differences could be detected in whole-cell proteins between the parent and mutant. The mutant totally lacked extracellular hemolytic and cytotoxic activity. Lysates of whole cells of the mutant contained weak hemolytic activity, and the 110 kDa protein could be detected by immunoblotting. Neutralization titers were negative in pigs immunized with the mutant or purified, denatured hemolysin, although enzyme-immunoassay titers were detected. Four additional independently isolated non-hemolytic mutants were avirulent in pigs and mice at doses greater than 10 times the lethal dose of the parent. Neither pigs nor mice were protected against lethal infection following immunization with the non-hemolytic mutant. We conclude that the 110 kDa hemolysin plays an important role in bacterial virulence and the pathogenesis of pleuropneumonia, and that sufficiently high levels of neutralizing antibodies to the 110 kDa hemolysin may be required for protection of pigs against disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895928     DOI: 10.1016/0882-4010(91)90012-y

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  18 in total

1.  The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice.

Authors:  J N Seah; J Frey; J Kwang
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs.

Authors:  E M Kamp; N Stockhofe-Zurwieden; L A van Leengoed; M A Smits
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 4.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

5.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model.

Authors:  S K Highlander; N D Fedorova; D M Dusek; R Panciera; L E Alvarez; C Rinehart
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Molecular characterization of an RTX toxin determinant from Actinobacillus suis.

Authors:  L L Burrows; R Y Lo
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Transposon mutagenesis in Actinobacillus pleuropneumoniae with a Tn10 derivative.

Authors:  R I Tascon; E F Rodriguez-Ferri; C B Gutierrez-Martin; I Rodriguez-Barbosa; P Berche; J A Vazquez-Boland
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

9.  Purification and characterization of a protease from Actinobacillus pleuropneumoniae serotype 1, an antigen common to all the serotypes.

Authors:  E Negrete-Abascal; V R Tenorio; A L Guerrero; R M García; M E Reyes; M de la Garza
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

10.  Structural analysis of the Actinobacillus pleuropneumoniae-RTX-toxin I (ApxI) operon.

Authors:  R Jansen; J Briaire; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.